Company news

Impedimed Limited news in 2017

Impedimed Limited's news releases, calls and decks from 2017, newest first.

View company

US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO

December 26, 2017

L-Dex Abstracts to be Presented at Breast Cancer Symposium

November 8, 2017

2018 Reimbursement Amounts Published by CMS

November 5, 2017

Multi-year Exclusive Distribution Agreement Signed

October 30, 2017

Appendix 4C - Quarter ended 30 September 2017

October 24, 2017

Shipments of SOZO with L-Dex Commence in the US

October 22, 2017

New Study Reports Superior Clinical Outcomes Utilising L-Dex

August 24, 2017

Appendix 4E - year ended 30 June 2017

August 22, 2017

Heart Failure 510(k) Application for SOZO Submitted to FDA

August 21, 2017

US FDA 510(k) Clearance Issued for SOZO with L-Dex

August 14, 2017

First patient enrolled in SOZO CHF Trial at Scripps Health

August 8, 2017

Appendix 4C - Quarter ended 30 June 2017

July 23, 2017

IPD Submits FDA 510(k) Application for SOZO for Lymphoedema

July 16, 2017

L-Dex Recommended in Clinical Practice Guidelines

July 4, 2017

SOZO obtains CE Mark for Heart Failure Patient Monitoring

June 20, 2017

Macquarie University Commences Lymphoedema Study Using Sozo

June 14, 2017

L-Dex Study - Significant Reduction in Clinical Lymphoedema

May 17, 2017

March 2017 Quarter Results & Investor Conference Call

April 25, 2017

SOZO Shipped to Vanderbilt to Commence At-Home Study

April 23, 2017

Placement of First SOZO Unit at Scripps Health

March 6, 2017

Appendix 4D and Financial Report 31 December 2016

February 23, 2017

Appendix 4C - Quarter Ended 31 December 2016

January 30, 2017

Decks in 2017